跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POLIVY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
POLIVY
Authorized
STANDARD
POLIVY
Hoffmann-La Roche Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a38c54377a603788
Company
Hoffmann-La Roche Limited
Type
Standard
Approval Details
Approval Id
a38c54377a603788
Drug Approval Canada Name
POLIVY
Product Name
POLIVY
Status
Marketed
Status Date
2021-10-26
Original Market Date
2021-10-26
Din
02515431
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription , Schedule D
Ahfs
10:00.00
Atc Original
L01FX14 POLATUZUMAB VEDOTIN
Atc Name
l 01 fx 14
Aig Number
0162275002
Company Name
Hoffmann-La Roche Limited
Company Address
7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8
Active Ingredients
POLATUZUMAB VEDOTIN
30 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a38c54377a603788
Type
Standard
Back to Health Canada Approvals